Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemiaLeukemia, 2019-11, Vol.33 (11), p.2575-2584 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;COPYRIGHT 2019 Nature Publishing Group ;The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0887-6924 ;EISSN: 1476-5551 ;DOI: 10.1038/s41375-019-0472-2 ;PMID: 30967620Full text available |
2 |
Material Type: Article
|
![]() |
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50Journal of clinical oncology, 2021-07, Vol.39 (21), p.2339-2349 [Peer Reviewed Journal]2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.00174 ;PMID: 33872070Full text available |
3 |
Material Type: Article
|
![]() |
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate CancerJournal of clinical oncology, 2017-06, Vol.35 (17), p.1884-1890 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.71.7397 ;PMID: 28296582Full text available |
4 |
Material Type: Article
|
![]() |
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) VariantNew England Journal of Medicine, 2021-08, Vol.385 (7), p.585-594 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108891 ;PMID: 34289274Digital Resources/Online E-Resources |
5 |
Material Type: Article
|
![]() |
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164Journal of clinical oncology, 2020-01, Vol.38 (1), p.11-19 [Peer Reviewed Journal]2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.02107 ;PMID: 31725351Full text available |
6 |
Material Type: Article
|
![]() |
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)Journal of clinical oncology, 2018-07, Vol.36 (20), p.2017-2023 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2018.78.8034 ;PMID: 29746227Full text available |
7 |
Material Type: Article
|
![]() |
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemicAnnals of oncology, 2020-08, Vol.31 (8), p.1065-1074 [Peer Reviewed Journal]2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2020 The Author(s) 2020 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.05.009 ;PMID: 32442581Full text available |
8 |
Material Type: Article
|
![]() |
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast CancerJournal of clinical oncology, 2017-11, Vol.35 (32), p.3638-3646 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2017.75.6155 ;PMID: 28968163Full text available |
9 |
Material Type: Article
|
![]() |
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 TrialCancer discovery, 2017-06, Vol.7 (6), p.586-5952017 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-16-1396 ;PMID: 28365644Full text available |
10 |
Material Type: Article
|
![]() |
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized PatientsThe New England journal of medicine, 2022-02, Vol.386 (6), p.509-520 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2116044 ;PMID: 34914868Full text available |
11 |
Material Type: Article
|
![]() |
AKI in Hospitalized Patients with COVID-19Journal of the American Society of Nephrology, 2021-01, Vol.32 (1), p.151-160 [Peer Reviewed Journal]Copyright © 2021 by the American Society of Nephrology. ;Copyright © 2021 by the American Society of Nephrology 2021 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/ASN.2020050615 ;PMID: 32883700Full text available |
12 |
Material Type: Article
|
![]() |
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingThe New England journal of medicine, 2021-04, Vol.384 (15), p.1412-1423 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2101765 ;PMID: 33626250Full text available |
13 |
Material Type: Article
|
![]() |
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 InfectionJournal of the American College of Cardiology, 2020-08, Vol.76 (5), p.533-546 [Peer Reviewed Journal]2020 ;Published by Elsevier Inc. ;COPYRIGHT 2020 Elsevier B.V. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.06.007 ;PMID: 32517963Full text available |
14 |
Material Type: Article
|
![]() |
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialThe Lancet (British edition), 2021-05, Vol.397 (10285), p.1637-1645 [Peer Reviewed Journal]2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00676-0 ;PMID: 33933206Full text available |
15 |
Material Type: Article
|
![]() |
Effective treatment of severe COVID-19 patients with tocilizumabProceedings of the National Academy of Sciences - PNAS, 2020-05, Vol.117 (20), p.10970-10975 [Peer Reviewed Journal]Copyright © 2020 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences May 19, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2005615117 ;PMID: 32350134Full text available |
16 |
Material Type: Article
|
![]() |
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trialBlood, 2020-06, Vol.135 (24), p.2137-2145 [Peer Reviewed Journal]2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020004856 ;PMID: 32219442Full text available |
17 |
Material Type: Article
|
![]() |
Hemicraniectomy in Older Patients with Extensive Middle-Cerebral-Artery StrokeThe New England journal of medicine, 2014-03, Vol.370 (12), p.1091-1100 [Peer Reviewed Journal]Copyright © 2014 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1311367 ;PMID: 24645942 ;CODEN: NEJMAGFull text available |
18 |
Material Type: Article
|
![]() |
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid TumorsJournal of clinical oncology, 2018-06, Vol.36 (16), p.1611-1618 [Peer Reviewed Journal]2018 by American Society of Clinical Oncology 2018 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.76.2229 ;PMID: 29437535Full text available |
19 |
Material Type: Article
|
![]() |
Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 TrialJournal of clinical oncology, 2019-05, Vol.37 (15), p.1316-1325 [Peer Reviewed Journal]2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.18.00622 ;PMID: 30943123Full text available |
20 |
Material Type: Article
|
![]() |
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trialThe lancet oncology, 2016-08, Vol.17 (8), p.1047-1060 [Peer Reviewed Journal]Dearnaley et al. Open Access article distributed under the terms of CC BY ;2016 Dearnaley et al. Open Access article distributed under the terms of CC BY ;Copyright © 2016 Dearnaley et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Aug 01, 2016 ;2016 Dearnaley et al. Open Access article distributed under the terms of CC BY 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30102-4 ;PMID: 27339115 ;CODEN: LANCAOFull text available |